From ADCs to Treatment De-escalation: What’s Next in Advanced Breast Cancer?

At ESMO26, Prof. Sara Tolaney discusses evolving strategies in advanced breast cancer, from ADC-based treatment and endocrine resistance to personalized maintenance and treatment de-escalation in HER2-positive disease.

Library